Cargando…

Promoter Hypermethylation of the ATM Gene as a Novel Biomarker for Breast Cancer

BACKGROUND: Breast cancer may be induced by activation of protooncogenes to oncogenes and in many cases inactivation of tumor suppressor genes. Ataxia telangiectasia mutated (ATM) is an important tumor suppressor gene which plays central roles in the maintenance of genomic integrity by activating ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Begam, Nasrin, Jamil, Kaiser, Raju, Suryanarayana G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773784/ https://www.ncbi.nlm.nih.gov/pubmed/29172272 http://dx.doi.org/10.22034/APJCP.2017.18.11.3003

Ejemplares similares

Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients
por: Flanagan, James M., et al.
Publicado: (2009)

Hypermethylated genes as biomarkers of breast cancer
por: Fackler, MJ, et al.
Publicado: (2009)

Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2021)

Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer
por: Sayar, Nilufer, et al.
Publicado: (2015)

Analysis of hypermethylation and expression profiles of APC and ATM genes in patients with oral squamous cell carcinoma
por: Rigi-Ladiz, Mohammad Ayub, et al.
Publicado: (2011)

Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer
por: Ng, Jennifer Mun-Kar, et al.
Publicado: (2015)

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
por: Kloten, Vera, et al.
Publicado: (2013)

Prognostic Relevance of Promoter Hypermethylation of Multiple Genes in Breast Cancer Patients
por: Sharma, Gayatri, et al.
Publicado: (2009)

Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
por: Jin, Z, et al.
Publicado: (2001)

In silico evidence of signaling pathways of notch mediated networks in leukemia
por: Jamil, Kaiser, et al.
Publicado: (2012)

Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer
por: Strelnikov, Vladimir V., et al.
Publicado: (2021)

Rare variants in the ATM gene and risk of breast cancer
por: Goldgar, David E, et al.
Publicado: (2011)

Promoter hypermethylation profiling of distant breast cancer metastases
por: Schrijver, Willemijne A. M. E., et al.
Publicado: (2015)

Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2007)

Variants in the ATM gene and breast cancer susceptibility
por: Milne, Roger L
Publicado: (2009)

NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients
por: Jandrey, Elisa H. F., et al.
Publicado: (2019)

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk
por: Cho, Yoon Hee, et al.
Publicado: (2015)

APC Promoter Hypermethylation as a Prognostic Marker in Breast Cancer Patients
por: Saelee, Pensri, et al.
Publicado: (2020)

SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection
por: Mijnes, Jolein, et al.
Publicado: (2019)

Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis
por: Zurita, Mercedes, et al.
Publicado: (2010)

Promoter hypermethylation of neural-related genes is compatible with stemness in solid cancers
por: Idris, Musa, et al.
Publicado: (2023)

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
por: Buffart, T E, et al.
Publicado: (2008)

Low Levels of BNIP3 Promoter Hypermethylation in Invasive Breast Cancer
por: van Diest, Paul J., et al.
Publicado: (2010)

Distinct Functional Patterns of Gene Promoter Hypomethylation and Hypermethylation in Cancer Genomes
por: Shen, Xiaopei, et al.
Publicado: (2012)

ATM gene mutations in sporadic breast cancer patients from Brazil
por: Mangone, Flavia Rotea, et al.
Publicado: (2015)

The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
por: Zhang, Wenfan, et al.
Publicado: (2022)

Characteristic promoter hypermethylation signatures in male germ cell tumors
por: Koul, Sanjay, et al.
Publicado: (2002)

The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice
por: Stucci, Luigia Stefania, et al.
Publicado: (2021)

Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer
por: Moon, Ji Wook, et al.
Publicado: (2014)

ATM mutations associated with breast cancer
por: Gatti, RA, et al.
Publicado: (2005)

Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer
por: Minatani, Naoko, et al.
Publicado: (2016)

Promoter-Wide Hypermethylation of the Ribosomal RNA Gene Promoter in the Suicide Brain
por: McGowan, Patrick O., et al.
Publicado: (2008)

CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer
por: Caldeira, José Roberto F, et al.
Publicado: (2006)

Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification
por: Kornegoor, Robert, et al.
Publicado: (2012)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target
por: Hung, Chin-Sheng, et al.
Publicado: (2018)

ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma
por: Seniski, Gerusa G, et al.
Publicado: (2009)

Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer
por: Chen, Cheng, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pfo22lj7ga8hhkuhih74oe6j9e